Hangzhou Jiuyuan Genetic Biopharmaceutic

About Hangzhou Jiuyuan Genetic Biopharmaceutic

We are a leading biopharmaceutical company firstly developed the following products in China: rhG-CSF (filgrastim), Pegfilgrastim, Liraglutide(recombinant),Enoxaparin sodium, Fulvestrant, Interleukin-11, Palonosetron Hydrochloride, rhBMP-2 , Fosaprepitant dimeglumine. Our product pipeline include: Semaglutide (recombinant), Recombinant Hyaluronidase,  Avatrombopag maleate, Bone repair material with rhBMP-2 - Bone repair, Romosozumab,Daratumumab, Emicizumab, Amylin analog, SIRPα- specific monoclonal antibody.

Certifications
  • CE
    CE
  • FDA
    FDA
  • GMP
    GMP
  • ISO
    ISO
  • Other
  • Country/Region:
    China
  • On CPHI since:
    2015
  • Certificates:
    5
  • Employees:
    1000 - 4999
Company types
Manufacturer/Innovator
Contact info
Meet us at

CPHI & PMEC China 2026

Shanghai New International Expo Center
16 Jun 2026 - 18 Jun 2026

CPHI Milan 2026

Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026

Products from Hangzhou Jiuyuan Genetic Biopharmaceutic (19)